| Dr Sean Patrick Dineen, MD | |
|
800 Rose St, Ukmc -c224, Lexington, KY 40536-0293 | |
| (859) 323-6346 | |
| Not Available |
| Full Name | Dr Sean Patrick Dineen |
|---|---|
| Gender | Male |
| Speciality | Surgical Oncology |
| Experience | 21 Years |
| Location | 800 Rose St, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083737332 | NPI | - | NPPES |
| 319395501 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | M5691 (Texas) | Secondary |
| 208600000X | Surgery | 48175 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc | 2264337021 | 920 |
News Archive
Boehringer Ingelheim and Eli Lilly and Company today announced that they have received a positive opinion from the European Medicines Agency's medicinal committee recommending approval of Jentadueto,which combines the DPP-4 inhibitor, linagliptin and metformin in a single tablet. If approved by the European Commission, linagliptin/metformin hydrochloride (HCl) will provide a new, single-tablet treatment option, taken twice-daily, for adults with Type 2 Diabetes who need to improve control of their blood glucose.
Intellect Neurosciences, Inc., a biopharmaceutical company with internal preclinical and clinical-stage pipelines, as well as multiple licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a patent from the United States Patent and Trademark Office (USPTO) related to its internal Alzheimer's disease (AD) monoclonal antibody program.
PatientPop, the leader in practice growth technology designed for healthcare providers, today introduced automatic Google Posts with one-click appointment booking to customers.
Significant research funding in the form of a five-year, $12.1 million U19 Grant from the National Institutes of Health has been awarded to a collaboration of research teams co-led by Dartmouth's Christopher Amos, PhD, to study and improve precision of lung cancer risk and screening.
The First Lady of the Dominican Republic, Dr. Margarita Cedeno de Fernandez, today urged the countries of the Americas to redouble their efforts to eliminate rubella and congenital rubella syndrome as well as all other vaccine-preventable diseases.
› Verified 4 days ago
| Entity Name | H Lee Moffitt Cancer Ctr & Res Inst Life Time Cancer Scrn Ctr Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306833595 PECOS PAC ID: 2264337021 Enrollment ID: O20031204000575 |
News Archive
Boehringer Ingelheim and Eli Lilly and Company today announced that they have received a positive opinion from the European Medicines Agency's medicinal committee recommending approval of Jentadueto,which combines the DPP-4 inhibitor, linagliptin and metformin in a single tablet. If approved by the European Commission, linagliptin/metformin hydrochloride (HCl) will provide a new, single-tablet treatment option, taken twice-daily, for adults with Type 2 Diabetes who need to improve control of their blood glucose.
Intellect Neurosciences, Inc., a biopharmaceutical company with internal preclinical and clinical-stage pipelines, as well as multiple licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a patent from the United States Patent and Trademark Office (USPTO) related to its internal Alzheimer's disease (AD) monoclonal antibody program.
PatientPop, the leader in practice growth technology designed for healthcare providers, today introduced automatic Google Posts with one-click appointment booking to customers.
Significant research funding in the form of a five-year, $12.1 million U19 Grant from the National Institutes of Health has been awarded to a collaboration of research teams co-led by Dartmouth's Christopher Amos, PhD, to study and improve precision of lung cancer risk and screening.
The First Lady of the Dominican Republic, Dr. Margarita Cedeno de Fernandez, today urged the countries of the Americas to redouble their efforts to eliminate rubella and congenital rubella syndrome as well as all other vaccine-preventable diseases.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sean Patrick Dineen, MD 800 Rose St, Ukmc -c224, Lexington, KY 40536-0293 Ph: (859) 323-6346 | Dr Sean Patrick Dineen, MD 800 Rose St, Ukmc -c224, Lexington, KY 40536-0293 Ph: (859) 323-6346 |
News Archive
Boehringer Ingelheim and Eli Lilly and Company today announced that they have received a positive opinion from the European Medicines Agency's medicinal committee recommending approval of Jentadueto,which combines the DPP-4 inhibitor, linagliptin and metformin in a single tablet. If approved by the European Commission, linagliptin/metformin hydrochloride (HCl) will provide a new, single-tablet treatment option, taken twice-daily, for adults with Type 2 Diabetes who need to improve control of their blood glucose.
Intellect Neurosciences, Inc., a biopharmaceutical company with internal preclinical and clinical-stage pipelines, as well as multiple licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a patent from the United States Patent and Trademark Office (USPTO) related to its internal Alzheimer's disease (AD) monoclonal antibody program.
PatientPop, the leader in practice growth technology designed for healthcare providers, today introduced automatic Google Posts with one-click appointment booking to customers.
Significant research funding in the form of a five-year, $12.1 million U19 Grant from the National Institutes of Health has been awarded to a collaboration of research teams co-led by Dartmouth's Christopher Amos, PhD, to study and improve precision of lung cancer risk and screening.
The First Lady of the Dominican Republic, Dr. Margarita Cedeno de Fernandez, today urged the countries of the Americas to redouble their efforts to eliminate rubella and congenital rubella syndrome as well as all other vaccine-preventable diseases.
› Verified 4 days ago
Keith Menes, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2350 Regency Rd Ste A, Lexington, KY 40503 Phone: 859-278-4960 Fax: 859-523-2277 | |
Melissa Ranney Newcomb, MD Surgery Medicare: Medicare Enrolled Practice Location: Ukmc General Surgery, 800 Rose St., Lexington, KY 40536 Phone: 859-323-6346 Fax: 859-323-6840 | |
Cheryl Diana Richie, Surgery Medicare: Accepting Medicare Assignments Practice Location: 138 Leader Ave, Lexington, KY 40508 Phone: 859-323-5261 | |
Dr. Varun Jain, M.D Surgery Medicare: Medicare Enrolled Practice Location: 740 S Limestone Ste L104, Lexington, KY 40536 Phone: 859-257-3253 Fax: 859-323-1203 | |
Wanda Lam, MD Surgery Medicare: Medicare Enrolled Practice Location: 740 S Limestone, Lexington, KY 40536 Phone: 859-257-3253 Fax: 859-323-1203 | |
David J Worhunsky, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 800 Rose St, Lexington, KY 40536 Phone: 859-323-5625 | |
Veronica Morgan Jones, MD Surgery Medicare: Medicare Enrolled Practice Location: 800 Rose St Whitney Hendrickson Ste 134, Lexington, KY 40536 Phone: 859-323-6346 Fax: 859-323-6840 |